Woogene B&G Co., Ltd manufactures animal health products and veterinary medicines such as anti-infectives, pesticide, and antibiotics.  The Company also produces nutraceutical such as enzyme, and probiotics, feed supplement.

[Revised] Contract of Providing Shares as Collateral that Can Cause a Change of the Largest Shareholder

Outcomes of Annual Meeting of Shareholders

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Woogene B&G (018620 KS)

[Revised] Contract of Providing Shares as Collateral that Can Cause a Change of the Largest Shareholder

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Other Management Information(Voluntary Disclosure)(ê°ì¬ë³´ê³ ì ì ì¶ ì§ì°)

Reporting reasons for holding general shareholders' meeting on the most concentrated date

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

[Revised] Contract of Providing Shares as Collateral that Can Cause a Change of the Largest Shareholder

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Other Management Information(Voluntary Disclosure)(ê°ì¬ë³´ê³ ì ì ì¶ ì§ì°)

Reporting reasons for holding general shareholders' meeting on the most concentrated date

Other Management Information(Voluntary Disclosure)(ê°ì¬ë³´ê³ ì ì ì¶ ì§ì°)